External beam radiotherapy (EBRT) causes anxiety and claustrophobia in pediatric patients. To provide exact figures and radiation amounts, an appropriate sedation or anesthesia can be supplied. Alpha 2 agonist dexmedetomidine has been used for sedation and anesthesia in pediatric imaging. Dexmedetomidine has an advantage because it has minimal respiratory depression and no direct effects on myocardial function. We report repeated sedation with dexmedetomidine for 33 consecutive radiation therapies in 5 years old children. Dexmedetomidine is a selective α 2 -adrenoreceptor agonist that decreases sympathetic tone and attenuate the stress response to anesthesia and surgery. It was introduced during the 1990s as a sedative in the intensive care unit. Dexmedetomidine has no effect of myocardial function and minimal effect on respiratory function [4,5], these characteristics make an appealing agent for the ERBT in pediatric patients.We present a case about using of dexmedetomidine as the sole sedation anesthetics for 33 consecutive EBRT sessions in a 5 year old child.
CASE REPORTA 5 year old female child (111 cm, 21.4 kg) was admitted to hospital with nausea, vomiting and headache that had lasted for 4 weeks. Magnetic resonance imaging (MRI) revealed a contrast enhanced 3.7 × 4.3 cm lesion in left parietal lobe. A glioblastoma was suspected and confirmed histologically after craniotomy with tumor resection. After surgery, 33 consecutive radiation therapies (involved field, two co-axial isocentric field, fractionated; cumulative dose 61.2 Gy) were implemented for duration of 7 weeks. In order to plan proper radiation